Duality Technologies joins the fight against cancer with a new secure data collaboration toolkit enabling analytics and AI on Oncological Real-World Data
Retrieved on:
Tuesday, August 15, 2023
Real-World Evidence, Data management, PNAS, University of California, Berkeley, Theory of Computing Systems, Health, Big data, Dana–Farber Cancer Institute, Simons Institute for the Theory of Computing, Privacy, Innovation, Research, MIT, RWD, Confidentiality, Oncology, Organization, Pet, Computing, National academy, Science and technology in Asia, UC, Patient, Tel Aviv Sourasky Medical Center, RWE, Jiangsu University, Government, Clinical, Health information management, Real world data, Medical imaging, Nursing, Pharmaceutical industry, Duality
HOBOKEN, N.J., Aug. 15, 2023 /PRNewswire/ -- Several of the world's most prestigious medical research organizations have partnered with Duality Technologies, the leader in secure data collaboration for enterprises and government agencies, to deliver a major breakthrough in sharing Real-World patient data securely and efficiently to advance medical research and improve oncological patient outcomes.
Key Points:
- This data is used to generate Real-World Evidence (RWE), which is essential in the development and success of treatments.
- To reach sufficiently large cohorts of patients for research, and to enrich the data by linking data sets, medical centers must often collaborate with other organizations.
- This data collaboration challenge hinders progress in medical research, negatively affecting the pace at which new potentially life-saving cancer treatments are introduced to the public.
- Our joint study with Duality aimed and verified the accuracy of statistical oncology endpoints when done through encrypted data.